CVR Medical Corp. Stock Deutsche Boerse AG
Equities
B3BN
CA1266321084
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 EUR | -26.32% | -.--% | -.--% |
Sales 2020 | - | Sales 2021 | - | Capitalization | 3.6M 3.37M |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | -1M -935K | EV / Sales 2020 | - |
Net Debt 2020 | 360K 337K | Net Debt 2021 | 434K 405K | EV / Sales 2021 | - |
P/E ratio 2020 |
-11.5
x | P/E ratio 2021 |
-1.55
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 87.21% |
1 day | -26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Rhodes
CEO | Chief Executive Officer | - | 21-01-19 |
Paul S. Blunden
PSD | President | - | 16-10-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul S. Blunden
PSD | President | - | 16-10-19 |
Phillip Bendick
BRD | Director/Board Member | - | 20-02-12 |
Joseph Lynch
BRD | Director/Board Member | - | 20-02-16 |
1st Jan change | Capi. | |
---|---|---|
-18.88% | 11.03B | |
+53.75% | 3.5B | |
-32.50% | 2.23B | |
-14.31% | 2.16B | |
-26.83% | 1.54B | |
+28.55% | 1.12B | |
-3.28% | 737M | |
-23.50% | 477M | |
-43.27% | 411M |
- Stock Market
- Equities
- CVM.H Stock
- B3BN Stock